Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

CLLS — Cellectis S.A. SEC Filings | FilingIndex

CLLSNasdaq

Cellectis S.A.

Biological Products, (No Diagnostic Substances) · I0 · CIK 1627281

Cellectis S.A. develops and licenses gene-edited allogeneic CAR T-cell immunotherapies

+ Watch View on EDGAR ↗

$311M

Market cap

$2.94

Last close

+3.9%

1D

+4.3%

5D

22K

Volume

Price · last 39 sessions-20.5%

May 4L $2.79 · H $4.07Jun 29

412

Total filings

Jun 25, 2026

Last filing

12/31

Fiscal year end

All 6-K · 381 20-F · 11 SC 13G · 10 424B5 · 8 SC 13D · 2 SC 13D/A · 1

424B5424B5Feb 3, 2023 424B5424B5Feb 2, 2023 424B5424B5Jan 4, 2023 424B5424B5Mar 29, 2021 424B5424B5Dec 15, 2020 424B5

Similar companies

Comparable business profile · signals at a glance

IMTXImmatics N.V.$1.3B+0.4%RCUSArcus Biosciences, Inc.$3.0B+0.3%LCTXLineage Cell Therapeutics, Inc.$316.6M+5.5%RAREUltragenyx Pharmaceutical Inc.$2.4B-0.3%INKTMiNK Therapeutics, Inc.

424B5

Apr 6, 2018

424B5424B5Apr 4, 2018

424B5424B5Apr 3, 2018

$59.9M

+2.3%

PHVSPharvaris N.V.$2.1B+2.1%